Carroll Financial Associates’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $6K | Hold |
40
| – | – | ﹤0.01% | 1306 |
|
|
2021
Q3 | $10K | Hold |
40
| – | – | ﹤0.01% | 1229 |
|
|
2021
Q2 | $15K | Hold |
40
| – | – | ﹤0.01% | 1174 |
|
|
2021
Q1 | $21K | Hold |
40
| – | – | ﹤0.01% | 1006 |
|
|
2020
Q4 | $15K | Hold |
40
| – | – | ﹤0.01% | 1007 |
|
|
2020
Q3 | $15K | Hold |
40
| – | – | ﹤0.01% | 941 |
|
|
2020
Q2 | $19K | Hold |
40
| – | – | ﹤0.01% | 871 |
|
|
2020
Q1 | $14K | Hold |
40
| – | – | ﹤0.01% | 863 |
|
|
2019
Q4 | $28K | Hold |
40
| – | – | ﹤0.01% | 797 |
|
|
2019
Q3 | $25K | Hold |
40
| – | – | ﹤0.01% | 765 |
|
|
2019
Q2 | $34K | Hold |
40
| – | – | ﹤0.01% | 690 |
|
|
2019
Q1 | $23K | Hold |
40
| – | – | ﹤0.01% | 716 |
|
|
2018
Q4 | $13K | Hold |
40
| – | – | ﹤0.01% | 785 |
|
|
2018
Q3 | $19K | Hold |
40
| – | – | ﹤0.01% | 727 |
|
|
2018
Q2 | $18K | Hold |
40
| – | – | ﹤0.01% | 721 |
|
|
2018
Q1 | $23K | Hold |
40
| – | – | ﹤0.01% | 637 |
|
|
2017
Q4 | $24K | Hold |
40
| – | – | ﹤0.01% | 618 |
|
|
2017
Q3 | $39K | Hold |
40
| – | – | ﹤0.01% | 534 |
|
|
2017
Q2 | $37K | Hold |
40
| – | – | ﹤0.01% | 556 |
|
|
2017
Q1 | $38K | Hold |
40
| – | – | ﹤0.01% | 532 |
|
|
2016
Q4 | $32K | Hold |
40
| – | – | ﹤0.01% | 543 |
|
|
2016
Q3 | $33K | Hold |
40
| – | – | 0.01% | 549 |
|
|
2016
Q2 | $32K | Hold |
40
| – | – | 0.01% | 522 |
|
|
2016
Q1 | $44K | Buy |
+40
| New | +$44K | 0.01% | 452 |
|
|
2015
Q1 | – | Sell |
-20
| Closed | -$26K | – | 865 |
|
|
2014
Q4 | $26K | Buy |
+20
| New | +$26K | 0.02% | 343 |
|